| Product NDC: | 13537-309 |
| Proprietary Name: | ESIKA |
| Non Proprietary Name: | Octinoxate and Oxybenzone |
| Active Ingredient(s): | .05; .02 mg/mL; mg/mL & nbsp; Octinoxate and Oxybenzone |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | LOTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 13537-309 |
| Labeler Name: | Ventura Corporation (San Juan, P.R) |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part352 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20110517 |
| Package NDC: | 13537-309-02 |
| Package Description: | 1 BOTTLE in 1 BOX (13537-309-02) > 30 mL in 1 BOTTLE (13537-309-01) |
| NDC Code | 13537-309-02 |
| Proprietary Name | ESIKA |
| Package Description | 1 BOTTLE in 1 BOX (13537-309-02) > 30 mL in 1 BOTTLE (13537-309-01) |
| Product NDC | 13537-309 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Octinoxate and Oxybenzone |
| Dosage Form Name | LOTION |
| Route Name | TOPICAL |
| Start Marketing Date | 20110517 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Ventura Corporation (San Juan, P.R) |
| Substance Name | OCTINOXATE; OXYBENZONE |
| Strength Number | .05; .02 |
| Strength Unit | mg/mL; mg/mL |
| Pharmaceutical Classes |